ligand binding sites on BSA are located in subdomains IIA and IIIA, namely site I and site II. It has been reported that some small molecules including hybrids based on azole heterocyclic systems bind exclusively to specific sites, either to the tryptophan residue (site I) or to the tyrosine residue (site II) on BSA molecules.
2
Synthetic chemists are in continuous effort to design and synthesize versatile variety of hybrids based on azole heterocyclic systems.
3−5 Nitrogen-based heterocyclic systems have been reported to have various pharmacological applications. 6 The 1,2,4-triazole core has been found to possess interesting biological activities, namely antiinflammatory, 7 anticancer, 8 insecticidal, 9 antiviral, 10 antioxidant, 11 analgesic, 12 antimicrobial, 13 anticonvulsant, and antidepressant 14 activities. Triazole derivatives have also been used as fungicides in agrichemicals as well as in pharmaceutical applications for the treatment of topical and systematic fungal infections. The widespread use of triazole derivatives has generated extensive concerns regarding their distribution, free concentration, and metabolism within the body, which are affected by the ligand/protein interactions in the blood stream.
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Based on these findings, it was of interest to synthesize a new series of triazole derivatives and evaluate their interaction with BSA by studying the effect of varying substituents on the binding strength of the triazole derivatives. The binding mode and binding site of the triazoles to BSA molecules were also studied. These findings may provide basic data on the binding mechanism of the synthesized triazole derivatives with blood carrier proteins, which can be helpful for the security of human health when applied in pharmaceutical formulations.
Results and discussion

Chemistry
N -(substituted)-2-(5-(1-(4-nitrophenylsulfonyl)piperidin-4-yl)-4-phenyl-4H -1,2,4-triazol-3-ylthio)acetamides (8a-8i; Table 1 
Compound 8e, a yellowish amorphous solid, was synthesized in good yield with the molecular formula 
stretching, (C-N) stretching, and (C-S) stretching, respectively. On the basis of these accumulative spectral data, the structure of compound 8e was determined as N -(2,3-
Biological activities
BSA binding study
Triazole and its derivatives have been known for their wide range of biological activities, such as antibacterial, antispasmodic, antiinflammatory, antiplatelet agglomeration and proliferation inhibition, and induction of differentiation and apoptosis of tumor cells. 16 In this study, the interaction of selected triazole derivatives with BSA (BSA) was investigated in order to provide some useful information on the therapeutic effects of these compounds in pharmacology and pharmacodynamics. Table 2 . Table 2 . Stern-Volmer quenching constant and quenching rate constant of the different compound-BSA systems. Fluorescence quenching can be classified as either a static or dynamic process and is caused by different mechanisms including excited state reactions, molecular rearrangements, energy transfer, formation of ground state complexes, and collisional quenching. 17 The type of quenching mechanism is usually interpreted by the 
Stern-Volmer equation:
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where F o and F are the fluorescence intensities of BSA before and after addition of quencher, respectively;
K sv is the Stern-Volmer quenching constant; [Q] is the concentration of the quencher; K q is the apparent bimolecular quenching rate constant; and τ o is the average lifetime of the biomolecule without the quencher and its value is 10 −8 s.
19
In all cases, the calculated K q values were found to be larger than the maximum scattering collision quenching rate constant (2 × 10 10 M −1 s −1 ) in dynamic quenching. This indicated that the fluorescence quenching process of BSA with the triazole compounds, as well as warfarin and ibuprofen, was primarily governed by a static quenching mechanism, rather than a dynamic one.
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The binding constant K a and the number of binding sites n of synthesized compounds can be calculated by using the following double logarithm equation:
K a and n are obtained from the intercept and slope of a linear plot of log (
, and the values are summarized in Table 3 . The different substituents on the triazole ring were found to affect the binding ability of the 1,2,4-triazolebased derivatives with BSA. The presence of the methyl group at the meta position enhanced the affinity of the triazole derivative to BSA (entries 4 and 5), giving rise to higher K a values. This might be due to an increase in molecular size, providing a larger hydrophobic area that can interact with the hydrophobic surface on the protein molecule. 21 However, when the methyl group was at the para position, a decrease in binding constant was observed (entry 4).
Thermodynamics of BSA binding
The interactions between the triazole compounds and BSA may involve hydrophobic, electrostatic, or van der Waals forces as well as hydrogen bonding. In order to elucidate the types of interaction occurring between triazole compounds and BSA, thermodynamic parameters such as free energy ( ∆G), enthalpy ( ∆ H), and entropy ( ∆ S) were determined and these were used to demonstrate the type of binding taking place.
The four binding modes through which small molecules can bind to biological macromolecules are hydrogen bonds, hydrophobic forces, electrostatic forces, and van der Waals interactions. These interactions can be described by thermodynamic parameters of enthalpy and entropy energies. If ∆H <0 and ∆ S <0, van der Waals forces and hydrogen bonds play major roles in the binding reaction. If ∆ H >0 and ∆ S >0, hydrophobic interactions are dominant. Electrostatic forces are more prominent when ∆ H <0 and ∆S >0.
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The thermodynamic parameters of selected triazole analogs binding to BSA were studied at three different temperatures. ∆ G, ∆ H, and ∆ S values were estimated using Eqs. (3) and (4):
where T is the experimental temperature, K a is the binding constant at T, and R is the gas constant. The temperature-dependent thermodynamic parameters, ∆H and ∆ S, can be analyzed using the van't Hoff formula:
where K a is the binding constant, R is the gas constant, and T is experimental temperature. To obtain values of ∆ H and ∆S, the graph of ln K a against 1/T was plotted ( Figure 4 ) and the results are tabulated in Table   4 . From the slope and intercept of the linear van't Hoff plot, values of ∆ H and ∆ S were obtained and the free energy change, ∆ G, was also estimated using the following relationship:
1 Figure 4 . van't Hoff plots for BSA-(8a, 8c, 8h) systems.
From Figure 3 , it can be observed that there is good linearity of the van't Hoff plots. The negative ∆H and negative ∆S indicated that the interactions with 8a-8i are enthalpically driven but not entropically favorable. Moreover, the negative ∆G values at all temperatures for 8a-8i proved that the interactions between the synthesized compounds with BSA were spontaneous. From the thermodynamic parameters, the negative ∆H and ∆ S values indicated that van der Waals forces and hydrogen bonding play major roles in the binding of compounds 8a-8i to BSA and have a great contribution to the stability of the complex formed. The triazole derivatives contain electronegative atoms and therefore can form hydrogen bonds with the amino acid residues in BSA.
Site-selective binding of selected compounds on BSA in the presence of site markers
It is reported that the structure of BSA consists of three homologous domains named I, II, and III and each domain includes two subdomains called A and B. The major regions of ligand-binding sites on BSA are situated in hydrophobic cavities known as subdomains IIA (Sudlow's site 1) and IIIA (Sudlow's site II).
The binding locations are usually studied with site markers that have specific binding sites and that can help determine the drug-binding sites on BSA by performing competitive binding experiments. To determine the binding site of compounds 8a-8i on BSA, warfarin and ibuprofen were selected as site markers for site I and site II, respectively. A varied amount of compounds 8a-8i was added to a solution of site marker and BSA and the resulting mixture was excited at 295 nm.
The fluorescence quenching data of the 8a-8i and BSA system in the presence of site markers were analyzed using Eq. (2) and the results are tabulated in Table 5 . The binding constants significantly decreased in the presence of ibuprofen but to a lesser extent in the presence of warfarin. Therefore, this showed that ibuprofen competed with the triazole derivatives in the subdomain IIIA of BSA, demonstrating that the binding of the triazole derivatives with BSA primarily takes place at site II.
Synchronous study of the binding of 1,2,4-triazole analogs to BSA
Synchronous fluorescence spectroscopy was carried out to confirm the binding site of compounds 8a-8i with BSA by monitoring the change in the microenvironment surrounding Trp and Tyr residues. The shift in the position of the fluorescence emission maximum corresponded to modification of the polarity around Trp and Tyr residues. A blue shift of λ max indicated that the amino acid residues were situated in a more hydrophobic environment while a red shift of λ max implied that the amino acid residues were in a polar environment. It is possible to study the change in the conformation of BSA induced by triazole-based synthesized compounds by measuring the fluorescence intensity of BSA before and after the addition of the compound. From the literature information, the synchronous fluorescence spectra obtained at ∆λ = 15 nm and ∆λ = 60 nm corresponded to the Tyr and Trp residues, respectively. 23 The synchronous spectra for BSA-TDs are displayed in Figure 5 for ∆λ = 15 nm and in Figure 6 for ∆λ = 60 nm. The results revealed that the fluorescence intensity of both Trp and Tyr decreased with a notable red shift at maximum emission ∆λ = 15 nm in the presence of compounds 8a-8i, whereas no significant shift was observed at ∆λ = 60 nm for 8a-8i. This observation confirmed that the triazole derivatives were bound to the tyrosine residue of BSA, in a similar manner to that of ibuprofen.
Infrared spectroscopy is considered to be a useful technique to investigate the secondary structure of proteins. In the FT-IR region, amide I, II, and III vibrations are related to the frequencies of the bands, especially that of amide I, as it is more sensitive to change of the secondary structure. It was reported that the amide I peak is situated in the region of 1600-1700 cm −1 (mainly C =O stretching) and the amide II peak at 1548 cm −1 (C-N stretch coupled with N-H bending mode). 1 Comparing the FT-IR spectra of BSA with and without triazole-derived compounds 8a-8i, it was found that the peak of amide I, which corresponds to the (C =O) stretching, shifted from 1651.72 cm −1 to 1652.05 cm −1 , indicating that the secondary structure of BSA was altered due to the interaction between compounds 8a-8i and BSA. From FT-IR analysis, a change in the absorbance of BSA in the presence of compound 8a-8i was observed ( Figure 7 ). The spectrum of BSA deforms as the ratio of peak heights in the absence and in the presence of compounds 8a-8i (diluted and concentrated)
is different. This result indicates that the secondary structure of BSA has been altered due to the interaction of BSA with compounds 8a-8i. 
Conclusions
Results of the fluorescence studies showed that the triazole derivatives were able to interact with BSA, causing a static quenching of the fluorescence intensity of BSA in a similar way to that of the well-known drugs warfarin and ibuprofen. The presence and position of different substituents on the triazole ring was found to affect the binding affinity of the synthesized compounds for BSA. The thermodynamic parameters indicated that the binding between the triazole analogs and BSA was spontaneous and involved mostly van der Waals forces and hydrogen bonding. Synchronous fluorescence data and competitive binding of compounds 8a-8i in the presence of warfarin and ibuprofen illustrated that compounds 8a-8i were bound to the same binding site as that of ibuprofen, i.e. on tyrosine residues of BSA. This study showed that the 1,2,4-triazole-based compounds were able to bind to BSA and therefore can be effectively transported and eliminated in the body, which can be a useful guideline to open new avenues for the designing of the most suitable triazole derivatives for further drug design.
Experimental 3.1. General
All the chemicals were of analytical grade and were obtained from Sigma Aldrich and Alfa Aesar Ltd. and were provided by local chemical trading companies in Pakistan. Phosphate buffer (20 mM, pH 7.4), BSA, calf-thymus DNA, Tris-buffered saline (0.05 M, pH 7.6), and ethidium bromide were purchased from Sigma Aldrich (St. Louis, MO, USA). IR spectra were recorded on a Bruker Alpha FT-IR spectrometer. Aluminum plates coated with silica gel were used to confirm the purity of synthesized compounds with an n -hexane : ethyl acetate mobile phase on TLC and visualized with a UV 254 lamp. 1 H NMR (600 MHz, CDCl 3 ) , 13 C NMR (150 MHz, CDCl 3 ) , and EI-MS data were recorded using a Bruker spectrometer and JMS-HX-110 spectrometer, respectively.
Synthesis
Synthesis of ethyl 1-(4-nitrophenylsulfonyl)piperidin-4-carboxylate (3)
Ethyl 1-[(4-nitrophenyl)sulfonyl]piperidin-4-carboxylate (3) was synthesized by stirring 4-nitrobenzene sulfonyl chloride (1; 0.05 mol) with ethyl isonipecotate (2; 0.05 mol) at room temperature for 8 h in distilled water (30 mL). The pH of the reaction was maintained at 9-10 using 10% Na 2 CO 3 solution. Completion of the reaction was confirmed by TLC and then chilled distilled water was added to precipitate the product, which was filtered, washed, and dried.
Synthesis of 1-(4-nitrophenylsulfonyl)piperidine-4-carbohydrazide (4)
Ethyl 1-[(4-chlorophenyl)sulfonyl]piperidin-4-carboxylate (3; 0.043 mol) was refluxed with hydrazine monohydrate (0.043 mol) using ethanol as a solvent for 5 h. TLC was used to monitor the reaction. At the completion of reaction, an excess of chilled distilled water was added with continuous shaking and the reaction mixture was kept at ice-cold temperature for 5 h. The obtained precipitate was filtered, washed, and dried at room temperature.
Synthesis of 5-(1-(4-nitrophenylsulfonyl)piperidin-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiol (5)
Compound 4 (0.030 mol) was refluxed with phenyl isothiocyanate (0.030 mol) in methanol for 5 h. The uncyclized precipitates obtained were filtered, washed, dried, and refluxed with 10% KOH for 6 h in distilled water. At the completion of the reaction as monitored by TLC, diluted HCl was added to the mixture drop by drop with continuous shaking until the pH was 5. After 30 min an off-white solid, compound 5, was obtained, which was filtered, washed with distilled water, and dried at room temperature.
Synthesis of N -(substituted)-2-bromoacetamides (7a-8i)
Alkylaryl/aryl amines (6a-6i; 0.02 mol) were stirred with 2-bromoacetyl bromide (0.02 mol) in distilled water for 1 h. The pH was adjusted to 9-10 using 15% Na 2 CO 3 solution. The formed precipitates were filtered, washed with distilled water, and dried. Those products that were not obtained in precipitate form were extracted using chloroform.
Synthesis of N -(substituted)-2-(5-(1-(4-nitrophenylsulfonyl)piperidin-4-yl)-4-phenyl-4H -
1,2,4-triazol-3-ylthio)acetamide (8a-8i)
Compound 5 (0.0044 mol) was stirred with LiH in DMF (15 mL) for 30 min, and then an equimolar amount of N -(substituted)-2-bromoacetamides (7a-7i) was added. The whole mixture was stirred at room temperature for 2-4 h. The completion of the reaction was confirmed with TLC. Chilled distilled water was added after the completion of the reaction to obtain the targeted products, which were filtered, washed, and dried. solutions were excited at 295 nm and the intensities of the BSA solutions with and without compounds 8a-8i were recorded at 336 nm at 298 K. For thermodynamic studies of BSA and synthesized derivatives, the above experiment was repeated at other two temperatures, 303 K and 308 K, respectively, for each of the synthesized compounds 8a-8i. Thus, three sets of fluorescence spectra were obtained at three temperatures: 298, 303, and 308 K.
N -(2-Ethylphenyl)-2-(5-(1-(4-nitrophenylsulfonyl)piperidin-4-yl)-4-phenyl-4H -1,2,4-triazol-
3-ylthio)acetamide (8b)
For site-selective binding studies, fluorometric titration of BSA solution (3 mL, 3 µM) with and without site markers (ibuprofen or warfarin) was carried out with the solutions of synthesized compounds (1 mg/mL in DMSO solvent). The solutions were scanned using an excitation wavelength of 295 nm at 298 K.
For the synchronous binding studies (at ∆λ 15 nm or 60 nm), BSA solution (3 mL, 3 µM) was titrated with each compound of the synthesized series of triazole derivatives or the site markers at an excitation wavelength of 295 nm.
FT-IR spectroscopy
The FT-IR analysis was carried out on a Bruker Alpha FT-IR spectrometer. The spectrum of phosphate buffer in D 2 O was collected and subtracted from the spectrum of BSA to obtain the FT-IR spectrum of pure BSA. The change in the spectra of BSA before and after addition of compounds 8a-8i was analyzed.
